Apex Capital Management’s Natus Medical Inc NTUS Stock Holding History

Apex Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$14.7M	Buy	381,746 +62,350	+20%	+$2.32M	0.32%	87
2015 Q4	$15.3M	Buy	319,396 +24,483	+8%	+$1.13M	0.34%	83
2015 Q3	$11.6M	Buy	294,913 +26,131	+10%	+$1.11M	0.26%	91
2015 Q2	$11.4M	Buy	268,782 +35,207	+15%	+$1.4M	0.24%	91
2015 Q1	$9.22M	Buy	233,575 +50,717	+28%	+$1.87M	0.22%	97
2014 Q4	$6.59M	Buy	182,858 +47,505	+35%	+$1.6M	0.18%	106
2014 Q3	$3.99M	Buy	135,353 +70,367	+108%	+$1.94M	0.12%	136
2014 Q2	$1.63M	Buy	64,986 +9,003	+16%	+$223K	0.05%	179
2014 Q1	$1.44M	Buy	+55,983	New	+$1.41M	0.05%	179

Other funds holding NTUS

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Apex Capital Management's NTUS Position: Q1 2016 in Review

Apex Capital Management increased its Natus Medical Inc (NTUS) stake by 20% in Q1 2016, buying an estimated $2.32M and bringing the position to 381,746 shares worth $14.7M. The position accounts for 0.32% of the portfolio, ranked #87.

Apex Capital Management first reported a position in NTUS in Q1 2014 and has held it in 9 quarters since. The position peaked at $15.3M in Q4 2015. 207 funds tracked by Wall St. Rank hold NTUS as of Q1 2016.

Apex Capital Management held 381,746 shares of Natus Medical Inc worth $14.7M as of Q1 2016.
Apex Capital Management bought 62,350 Natus Medical Inc shares in Q1 2016, an estimated $2.32M.
Natus Medical Inc made up 0.32% of Apex Capital Management's portfolio in Q1 2016, its #87 holding.
Apex Capital Management first reported a position in Natus Medical Inc in Q1 2014 and has held it in 9 quarters since.
Apex Capital Management's Natus Medical Inc position peaked at $15.3M in Q4 2015.
207 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.